Congress Navigating The Future Of AI In Healthcare
La FDA concede la designazione di “breakthrough device” a un algoritmo di AI per la diagnosi dell’amiloidosi cardiaca
FDA encourages decentralized trials with new guidance
Wondering if Your Digital Health Product or Service is Subject to FDA Regulations?